Literature DB >> 15703016

Cryptogenic polyneuropathy: clinical and neurophysiological findings.

Jonas Lindh1, Martin Tondel, Anders Osterberg, Magnus Vrethem.   

Abstract

The purpose of this study was to describe the clinical and neurophysiological features of cryptogenic polyneuropathy in 168 patients in the neurological departments at three Swedish hospitals. The medical records of all patients aged 40-79 years with the diagnosis of cryptogenic polyneuropathy from 1993 to 2000 were analysed. One hundred and fourteen patients (68%) were men. The mean age at first symptom was 61 years and at diagnosis it was 64 years. Distal numbness (n = 115, 68%) was the most common symptom, but some patients complained of pain, pedal paresthesiae, and impairment of balance. The most common clinical findings were decreased or lost proprioception or sense of vibration (n = 135, 80%) and loss of ankle jerks (n = 131, 78%). Neurography in 139 patients showed mixed sensorimotor polyneuropathy of axonal or mixed axonal and demyelinating type in 97 (70%). Cryptogenic polyneuropathy is a slowly progressive sensorimotor nerve lesion of mainly axonal type. Men are more often affected than women. Most patients have a minor or moderate severe polyneuropathy.

Entities:  

Mesh:

Year:  2005        PMID: 15703016     DOI: 10.1111/j.1085-9489.2005.10106.x

Source DB:  PubMed          Journal:  J Peripher Nerv Syst        ISSN: 1085-9489            Impact factor:   3.494


  10 in total

Review 1.  Drug therapy for chronic idiopathic axonal polyneuropathy.

Authors:  Janna Warendorf; Alexander Fje Vrancken; Ivo N van Schaik; Richard Ac Hughes; Nicolette C Notermans
Journal:  Cochrane Database Syst Rev       Date:  2017-06-20

2.  Obstructive sleep apnoea: an underestimated cause of peripheral neuropathy.

Authors:  J de Seze
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-10-03       Impact factor: 10.154

Review 3.  Chronic idiopathic axonal polyneuropathy: a systematic review.

Authors:  Panagiotis Zis; Ptolemaios Georgios Sarrigiannis; Dasappaiah Ganesh Rao; Channa Hewamadduma; Marios Hadjivassiliou
Journal:  J Neurol       Date:  2016-03-09       Impact factor: 4.849

4.  Enriched enrollment randomized double-blind placebo-controlled cross-over trial with phenytoin cream in painful chronic idiopathic axonal polyneuropathy (EPHENE): a study protocol.

Authors:  David J Kopsky; Ruben P A van Eijk; Janna K Warendorf; Jan M Keppel Hesselink; Nicolette C Notermans; Alexander F J E Vrancken
Journal:  Trials       Date:  2022-10-22       Impact factor: 2.728

Review 5.  Cryptogenic sensory polyneuropathy.

Authors:  Mamatha Pasnoor; Mazen M Dimachkie; Richard J Barohn
Journal:  Neurol Clin       Date:  2013-03-13       Impact factor: 3.806

6.  Polymorphisms of GSTT1, GSTM1, and EPHX genotypes in patients with cryptogenic polyneuropathy: a case-control study.

Authors:  Jonas Lindh; Peter Söderkvist; Mats Fredrikson; Shahrzad Hosseininia; Martin Tondel; Bodil Persson; Magnus Vrethem
Journal:  Brain Behav       Date:  2011-11       Impact factor: 2.708

7.  Treatable childhood neuronopathy caused by mutations in riboflavin transporter RFVT2.

Authors:  A Reghan Foley; Manoj P Menezes; Amelie Pandraud; Michael A Gonzalez; Ahmad Al-Odaib; Alexander J Abrams; Kumiko Sugano; Atsushi Yonezawa; Adnan Y Manzur; Joshua Burns; Imelda Hughes; B Gary McCullagh; Heinz Jungbluth; Ming J Lim; Jean-Pierre Lin; Andre Megarbane; J Andoni Urtizberea; Ayaz H Shah; Jayne Antony; Richard Webster; Alexander Broomfield; Joanne Ng; Ann A Mathew; James J O'Byrne; Eva Forman; Mariacristina Scoto; Manish Prasad; Katherine O'Brien; Simon Olpin; Marcus Oppenheim; Iain Hargreaves; John M Land; Min X Wang; Kevin Carpenter; Rita Horvath; Volker Straub; Monkol Lek; Wendy Gold; Michael O Farrell; Sebastian Brandner; Rahul Phadke; Kazuo Matsubara; Michael L McGarvey; Steven S Scherer; Peter S Baxter; Mary D King; Peter Clayton; Shamima Rahman; Mary M Reilly; Robert A Ouvrier; John Christodoulou; Stephan Züchner; Francesco Muntoni; Henry Houlden
Journal:  Brain       Date:  2013-11-19       Impact factor: 13.501

8.  Urinary 2,5-hexanedione excretion in cryptogenic polyneuropathy compared to the general Swedish population.

Authors:  Bodil Persson; Magnus Vrethem; Nicola Murgia; Jonas Lindh; Anna-Lena Hällsten; Mats Fredrikson; Martin Tondel
Journal:  J Occup Med Toxicol       Date:  2013-07-30       Impact factor: 2.646

9.  Idiopathic small fiber neuropathy: phenotype, etiologies, and the search for fabry disease.

Authors:  Kristin Samuelsson; Konstantinos Kostulas; Magnus Vrethem; Arndt Rolfs; Rayomand Press
Journal:  J Clin Neurol       Date:  2014-04-23       Impact factor: 3.077

10.  Study of Autophagy and Microangiopathy in Sural Nerves of Patients with Chronic Idiopathic Axonal Polyneuropathy.

Authors:  Kristin Samuelsson; Ayman A M Osman; Maria Angeria; Mårten Risling; Simin Mohseni; Rayomand Press
Journal:  PLoS One       Date:  2016-09-23       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.